AR003967A1 - (22R) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-OXO-4-AZA-5ALFA- ANDROST-1-ENO-17BETA-CARBOXAMIDE EPIMERES, A PROCESS FOR YOUR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM. - Google Patents
(22R) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-OXO-4-AZA-5ALFA- ANDROST-1-ENO-17BETA-CARBOXAMIDE EPIMERES, A PROCESS FOR YOUR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM.Info
- Publication number
- AR003967A1 AR003967A1 ARP960103652A AR10365296A AR003967A1 AR 003967 A1 AR003967 A1 AR 003967A1 AR P960103652 A ARP960103652 A AR P960103652A AR 10365296 A AR10365296 A AR 10365296A AR 003967 A1 AR003967 A1 AR 003967A1
- Authority
- AR
- Argentina
- Prior art keywords
- 17beta
- androst
- phenylprop
- aza
- carboxamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a los epímeros:(22R)-N-(1,1,1-trifluoro-2- fenilprop-2-il)-3-oxo-4-aza-5alfa-androst-1-eno-17beta-carboxamida, y (22S)-N-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa-androst-1-eno-17beta- carboxamida, útiles como inhibidores de la enzima 5-reductasa de testosterona,procesos para su preparación y composiciones farmacéuticas que los contienen. Dichos epímeros responden a las fórmulas (I) y (II).The present invention relates to the epimers: (22R) -N- (1,1,1-trifluoro-2-phenylprop-2-yl) -3-oxo-4-aza-5alpha-androst-1-ene-17beta -carboxamide, and (22S) -N- (1,1,1-trifluoro-2-phenylprop-2-yl) -3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide, useful as testosterone 5-reductase enzyme inhibitors, processes for their preparation and pharmaceutical compositions containing them. Said epimers respond to formulas (I) and (II).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95MI001587A IT1275594B1 (en) | 1995-07-21 | 1995-07-21 | EPIMERS OF (22RS) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-BONE -4-AZA-5ALFA-ANDROST-1-ENE-17BETA-CARBOSSAMIDE |
Publications (1)
Publication Number | Publication Date |
---|---|
AR003967A1 true AR003967A1 (en) | 1998-09-30 |
Family
ID=11372032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960103652A AR003967A1 (en) | 1995-07-21 | 1996-07-19 | (22R) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-OXO-4-AZA-5ALFA- ANDROST-1-ENO-17BETA-CARBOXAMIDE EPIMERES, A PROCESS FOR YOUR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0782582A1 (en) |
JP (1) | JPH10506411A (en) |
KR (1) | KR970706298A (en) |
CN (1) | CN1159195A (en) |
AR (1) | AR003967A1 (en) |
AU (1) | AU6418396A (en) |
BR (1) | BR9606527A (en) |
CA (1) | CA2199273A1 (en) |
EA (1) | EA199700045A1 (en) |
HU (1) | HUP9702465A3 (en) |
IL (1) | IL120343A0 (en) |
IT (1) | IT1275594B1 (en) |
MX (1) | MX9701948A (en) |
NO (1) | NO971196L (en) |
PL (1) | PL319351A1 (en) |
WO (1) | WO1997004002A1 (en) |
ZA (1) | ZA965678B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6137399A (en) * | 1998-09-09 | 2000-03-27 | Merck & Co., Inc. | Method of determining and reducing the risk of bph-related urologic events |
DE60018707T2 (en) * | 1999-01-25 | 2006-02-09 | Smithkline Beecham Corp. | ANTI-ANDROGENES AND METHOD FOR THE TREATMENT OF DISEASES |
CN100355772C (en) * | 2005-12-28 | 2007-12-19 | 天津大学 | Steroid compound with 5-alpha reductase active and preparation process thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9216284D0 (en) * | 1992-07-31 | 1992-09-16 | Erba Carlo Spa | Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives |
-
1995
- 1995-07-21 IT IT95MI001587A patent/IT1275594B1/en active IP Right Grant
-
1996
- 1996-06-28 AU AU64183/96A patent/AU6418396A/en not_active Abandoned
- 1996-06-28 CN CN96190785A patent/CN1159195A/en active Pending
- 1996-06-28 BR BR9606527A patent/BR9606527A/en not_active Application Discontinuation
- 1996-06-28 CA CA002199273A patent/CA2199273A1/en not_active Abandoned
- 1996-06-28 IL IL12034396A patent/IL120343A0/en unknown
- 1996-06-28 MX MX9701948A patent/MX9701948A/en unknown
- 1996-06-28 HU HU9702465A patent/HUP9702465A3/en unknown
- 1996-06-28 PL PL96319351A patent/PL319351A1/en unknown
- 1996-06-28 EP EP96923968A patent/EP0782582A1/en not_active Withdrawn
- 1996-06-28 WO PCT/EP1996/002830 patent/WO1997004002A1/en not_active Application Discontinuation
- 1996-06-28 JP JP9506217A patent/JPH10506411A/en active Pending
- 1996-06-28 KR KR1019970701797A patent/KR970706298A/en not_active Application Discontinuation
- 1996-07-04 ZA ZA965678A patent/ZA965678B/en unknown
- 1996-07-19 AR ARP960103652A patent/AR003967A1/en unknown
-
1997
- 1997-03-14 NO NO971196A patent/NO971196L/en unknown
- 1997-04-18 EA EA199700045A patent/EA199700045A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO971196D0 (en) | 1997-03-14 |
AU6418396A (en) | 1997-02-18 |
CA2199273A1 (en) | 1997-02-06 |
PL319351A1 (en) | 1997-08-04 |
WO1997004002A1 (en) | 1997-02-06 |
ITMI951587A0 (en) | 1995-07-21 |
ITMI951587A1 (en) | 1997-01-21 |
HUP9702465A3 (en) | 1998-11-30 |
NO971196L (en) | 1997-03-14 |
HUP9702465A2 (en) | 1998-05-28 |
EA199700045A1 (en) | 1997-12-30 |
BR9606527A (en) | 1997-12-23 |
EP0782582A1 (en) | 1997-07-09 |
MX9701948A (en) | 1997-06-28 |
JPH10506411A (en) | 1998-06-23 |
CN1159195A (en) | 1997-09-10 |
IT1275594B1 (en) | 1997-08-06 |
KR970706298A (en) | 1997-11-03 |
ZA965678B (en) | 1997-01-24 |
IL120343A0 (en) | 1997-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9100990A (en) | MOMETASONE FUROATE MONOHYDRATE COMPOUND, THE PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS | |
ES2090713T3 (en) | ORGANIC SALTS OF N, N'-DIACETIL-CYSTINE. | |
GT199900102A (en) | PHENOXIPROPANOLAMINES, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2144192T3 (en) | NEW DERIVATIVES OF 1-PHENYL-2-DIMETHYL-AMINO-METHYL-CICLOHEXAN-1-OL, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
MX9304756A (en) | 9 - [(SUBSTITUTED GLYCLE) AMIDO] -6-DESMETIL-6-DESOXITETRACICLINAS, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2126766T3 (en) | TROPYL 7-AZAINDOL-3-ILCARBOXIAMIDES AS ANTI-TUSSIVE AGENT. | |
ECSP941104A (en) | DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
AR003220A1 (en) | ACILATED MELATONIN DERIVATIVES; PHARMACEUTICAL AND COSMETIC COMPOSITION AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT. | |
ES2052603T3 (en) | DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM. | |
CU23415B7 (en) | DERIVATIVES OF 2,6- QUINOLINILO AND 2,6- NAFTILO, PROCESSES FOR THEIR PREPARATION AND ITS USES | |
ES2111556T3 (en) | NEW ALKYL-HETEROCICLIC AMINES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2178055T3 (en) | SUBSTITUTED AMINIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
IT1265101B1 (en) | DERIVATIVES OF 2-AMINO-4-PHENYL-4-BUTYRIC BONE ACID | |
MX9305364A (en) | RETROVIRAL PROTEASE INHIBITING COMPOUNDS, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM. | |
ES2187738T3 (en) | DERIVATIVES OF FLAVONAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM. | |
IT1259419B (en) | 3-CARBOSE STEROIDS 17B - UNSATURATED SUBSTITUTES USEFUL AS INHIBITORS OF TESTOSTERONE 5 IN REDUCTASE | |
AR002017A1 (en) | DERIVATIVES OF FENIL-4-TIAZOLES SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND DERIVATIVES DEFENIL-4-TIAZOLES SUBSTITUTED USED IN SUCH PROCEDURE. | |
ES2159054T3 (en) | DI-TERC-BUTIL-PHENOLIC COMPOUNDS CONTAINING USEFUL SULFUR AS ANTI-INFLAMMATORY AGENTS. | |
ES2150461T3 (en) | DERIVATIVES OF AMIDINOPHENYLALANINE, PROCESS FOR ITS PREPARATION, ITS EMPLOYMENT AND AGENTS THAT CONTAIN THEM AS ANTICOAGULANTS. | |
AR003107A1 (en) | DERIVATIVES OF VITAMIN D FOR DERMATOLOGICAL USE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THE PREPARATION OF SUCH DERIVATIVES. | |
AR003967A1 (en) | (22R) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-OXO-4-AZA-5ALFA- ANDROST-1-ENO-17BETA-CARBOXAMIDE EPIMERES, A PROCESS FOR YOUR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM. | |
MX9307203A (en) | STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED. | |
UY26517A1 (en) | PIRAZOLO (4,3-E) NOVEL SUBSTITUTED DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THEIR USE AS MEDICINAL PRODUCTS AND PROCESSES TO PREPARE THEM | |
ES2175661T3 (en) | DERIVATIVES OF ISOFLAVONA, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ES2106800T3 (en) | COMPOSITION CONTAINING GAMMA OCTALACTONE, FERMENTATION PROCEDURE FOR ITS PRODUCTION AND ORGANOLEPTICAL USES OF THE SAME. |